How have LABFF shares performed in 2024?

Laboratorios Farmaceuticos Rovi's stock was trading at C$52.00 at the start of the year. Since then, LABFF shares have increased by 65.5% and is now trading at C$86.05. View the best growth stocks for 2024 here .

Are investors shorting Laboratorios Farmaceuticos Rovi?

Laboratorios Farmaceuticos Rovi saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 400 shares, a decline of 55.6% from the March 15th total of 900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days. View Laboratorios Farmaceuticos Rovi's Short Interest .

How do I buy shares of Laboratorios Farmaceuticos Rovi?

Shares of LABFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:LABFF

Laboratorios Farmaceuticos Rovi (LABFF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free LABFF Stock Alerts

C$86.05

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: C$86.05
▼
C$86.05
50-Day Range: C$52.00
▼
C$86.05
52-Week Range: C$86.05
▼
C$86.05

Volume: N/A
Average Volume: 1,300 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Short Interest

Get Laboratorios Farmaceuticos Rovi alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Laboratorios Farmaceuticos Rovi Stock (OTCMKTS:LABFF)

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

LABFF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LABFF Stock News Headlines

February 27, 2024 | msn.com

Laboratorios Farmaceuticos Rovi, S.A. reports FY results

February 10, 2024 | finance.yahoo.com

Laboratorios Farmaceuticos Rovi, S.A. (41L.F)

April 20, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

December 14, 2023 | es.investing.com

Laboratorios Farmaceuticos Rovi S.A. (ROVI)

November 11, 2023 | morningstar.com

Laboratorios Farmaceuticos Rovi SA ROVI

October 13, 2023 | investing.com

Laboratorios Richmond SACIF (RICH)

June 8, 2023 | msn.com

CAIXABANK BPI Maintains Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Buy Recommendation

June 8, 2023 | msn.com

ALANTRA EQUITIES Upgrades Laboratorios Farmaceuticos Rovi (XMAD:ROVI)

April 20, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

May 9, 2023 | investing.com

Laborat.Rovi (ROVI) Earnings Dates & Reports

April 25, 2023 | wsj.com

Laboratorios Farmaceuticos Rovi S.A.

April 11, 2023 | thestreet.com

At Rovi, Activist Investor's Years of Protests Against Executive Pay May Give Leverage on Board

April 6, 2023 | es.investing.com

Logista (LOG)

January 13, 2023 | finance.yahoo.com

Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)

November 22, 2022 | reuters.com

Laboratorios Farmaceuticos ROVI SA

See More Headlines

Receive LABFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Laboratorios Farmaceuticos Rovi and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:LABFF
CUSIP: N/A
CIK: N/A
Web: www.rovi.es
Phone: 34 91 021 30 00
Fax: N/A
Employees: 1,925
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Ivan Lopez-Belmonte Encina
Second Deputy Chairman & GM of Commercial and Development
Mr. Javier Lopez-Belmonte Encina
First Deputy Chairman, GM of Industrial Operations & CFO
Mr. Juan Lopez-Belmonte Encina
Chairman & CEO
Marta Campos Martínez
Head of Investor Relations
Ms. Mercedes Benítez del Castillo Sánchez
Legal Department Manager
Ms. Beatriz Ávila Alcalde
Sales Manager
Ms. Rosario Perucha Pérez
Marketing Manager
Mr. Francisco Javier Angulo García
Human Resources Manager
Mr. Gabriel Nunez Fernandez
Secretary

Key Competitors

View All Competitors

LABFF Stock Analysis - Frequently Asked Questions

How have LABFF shares performed in 2024?: Laboratorios Farmaceuticos Rovi's stock was trading at C$52.00 at the start of the year. Since then, LABFF shares have increased by 65.5% and is now trading at C$86.05.
View the best growth stocks for 2024 here.
Are investors shorting Laboratorios Farmaceuticos Rovi?: Laboratorios Farmaceuticos Rovi saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 400 shares, a decline of 55.6% from the March 15th total of 900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.
View Laboratorios Farmaceuticos Rovi's Short Interest.
How do I buy shares of Laboratorios Farmaceuticos Rovi?: Shares of LABFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LABFF) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial